6 Results for "

COT kinase inhibitor

" in MedChemExpress (MCE) Product Catalog:
Products (6)

6 Results for "COT kinase inhibitor" in MCE Product Catalog:

2
2 Cited Publications
Cat. No.: HY-12358
CAS No.: 871307-18-5
Purity:  99.42%
Research Areas:  

Inflammation/Immunology Cancer

Tpl2 Kinase Inhibitor 1 is a 3-pyridylmethylamino analog, and is a selective Tpl2 inhibitor (IC50=50 nM). Tpl2 consists of COT kinase and MAP3K8. Tpl2 Kinase Inhibitor 1 plays an important role in the regulation of the inflammatory response and the progression of some cancers .
loading...
    loading...
2
2 Cited Publications
Cat. No.: HY-32015
CAS No.: 915365-57-0
Target:  

MAP3K

Research Areas:  

Inflammation/Immunology

Cot inhibitor-1 (compound 28) is a selective tumor progression loci-2 (Tpl2) kinase inhibitor with an IC50 of 28 nM. Cot inhibitor-1 shows an inhibition of TNF-alpha production in human whole blood with an IC50 of 5.7 nM .
loading...
    loading...
Cat. No.: HY-169153
CAS No.: 1984784-12-4
Target:  

MAP3K

Research Areas:  

Inflammation/Immunology

Cot inhibitor-3 (Compound 33) is a potent and selective cancer osaka thyroid (COT) kinase inhibitor, with an IC50 of 4 nM. Cot inhibitor-3 can be used to prevent inflammation-driven lameness .
loading...
    loading...
Cat. No.: HY-12358A
CAS No.: 2934185-09-6
Research Areas:  

Inflammation/Immunology Cancer

Tpl2 Kinase Inhibitor 1 hydrochloride is a 3-pyridylmethylamino analog, and is a selective Tpl2 inhibitor (IC50=50 nM). Tpl2 consists of COT kinase and MAP3K8. Tpl2 Kinase Inhibitor 1 hydrochloride plays an important role in the regulation of the inflammatory response and the progression of some cancers .
loading...
    loading...
Cat. No.: HY-178726
CAS No.: 1984784-10-2
Cot-IN-4 (compound 32) is a potent cancer osaka thyroid (COT) kinase inhibitor with an IC50 of 6 nM. Cot-IN-4 inhibits the phosphorylation of ERK (IC50: 60 nM) and inhibits TNFα release (IC50: 60 nM). Cot-IN-4 also inhibits the formation of the pro-inflammatory cytokine IL-1β (IC50: 0.2 μM) in Uric acid (HY-B2130)-stimulated macrophages. Cot-IN-4 can be used for the study of inflammatory diseases .
loading...
    loading...
Cat. No.: HY-159074
CAS No.: 1798303-75-9
Target:  

MAP3K

Research Areas:  

Inflammation/Immunology Cancer

Cot-IN-5 (compound 1) is a potent ATP-competitive inhibitor of cancer osaka thyroid (COT). Cot-IN-5 can block COT kinase autophosphorylation .
loading...
    loading...